Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Nystatin 200000 unit oromucosal lozenge |
Is a |
Nystatin-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Skin antifungal agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Nystatin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
Has manufactured dose form |
Oromucosal lozenge |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
Is a |
Product manufactured as oromucosal dose form (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
Has unit of presentation |
Lozenge |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
Has basis of strength substance (attribute) |
Nystatin (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
Has presentation strength numerator unit (attribute) |
Unit |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
Has presentation strength denominator unit (attribute) |
Lozenge |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
Has presentation strength numerator value |
200000 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
Has precise active ingredient |
Nystatin (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
Is a |
Product containing only nystatin in oromucosal dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Nystatin 200000 unit oromucosal lozenge |
Plays role |
Antifungal therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|